home / stock / cyto / cyto news


CYTO News and Press, Altamira Therapeutics Ltd. From 03/25/24

Stock Information

Company Name: Altamira Therapeutics Ltd.
Stock Symbol: CYTO
Market: NASDAQ
Website: aurismedical.com

Menu

CYTO CYTO Quote CYTO Short CYTO News CYTO Articles CYTO Message Board
Get CYTO Alerts

News, Short Squeeze, Breakout and More Instantly...

CYTO - Altamira stock rallies 44% on Univercells mRNA collaboration

2024-03-25 12:19:30 ET More on Altamira Therapeutics Altamira Therapeutics stock jumps 7% as it files for second patent Financial information for Altamira Therapeutics Read the full article on Seeking Alpha For further details see: Altamira stock rallies ...

CYTO - Nkarta, Nuvation Bio, Canopy Growth among healthcare movers

2024-03-25 10:00:59 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run Johnson & Johnson, Boston Scientific least shorted stocks in S&...

CYTO - US Companies Moving the Markets, Morning edition
Mon, Mar 25, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Next.e.GO N.V. (EGOX) rose 90.8% to $0.075 on volume of 125,000,352 shares Fisker Inc. Class A (FSR) fell 28.2% to $0.08965 on volume of 60,620,440 shares Lucid Group Inc. (LCID) rose 17.3% to $3.2489 on volume of 33,193,462 shares ...

CYTO - Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines

HAMILTON, BERMUDA, March 25, 2024 (GLOBE NEWSWIRE) -- Univercells to test proprietary mRNA vaccine delivered with Altamira’s SemaPhore™ nanoparticles Targeting safer and accessible mRNA vaccines Altamira Therapeutics Ltd. (“Altamira” or the &#...

CYTO - Altamira Therapeutics' Peptide-Based Delivery Platform Shown to Enhance Potency of Commonly Used Gene Delivery Method as Published in Peer-Reviewed Journal

HAMILTON, BERMUDA, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus (AAV) vectors, commonly used in gene therapy, when integrating Altamira’s peptide-based delivery technology Increa...

CYTO - Adverum Biotechnologies, Cano Health among healthcare movers

2024-02-05 10:00:03 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...

CYTO - SILO, DWAC and LPL among pre-market losers

2024-01-25 08:25:44 ET More on Pre-market losers & stocks. LG Display Co Ltd (LPL) Q4 2023 Earnings Call Transcript LG Display: It Is The Long-Term Picture That Is Giving People Pause Silo Pharma stock rises after inking exclusive license deal with Medspray Pharm...

CYTO - Altamira Therapeutics stock jumps 7% as it files for second patent

2024-01-24 12:14:24 ET More on Altamira Therapeutics Altamira Therapeutics Ltd. (CYTO) Special Call Transcript Altamira shares sink over 40% on corporate, stock split updates Altamira stock rallies 130% in wake of Nasdaq update, unit sale Financial informatio...

CYTO - Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment

HAMILTON, BERMUDA, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altamira’s poly KRAS mut siRNA shown to knock down at least 65-91% of KRAS mutations in colorectal, non-small cell lung, and pancreatic cancer cell lines Fresh experimental data expected to strengthen Altamira’...

CYTO - HIVE, CLSK and HUT are among pre market gainers

2024-01-11 08:33:48 ET Moolec Science  ( MLEC ) +46% . Transphorm  ( TGAN ) +30% to buy Transphorm to expand power portfolio with GaN technology. Spectaire Holdings  ( SPEC ) +28% Launches into European Trucking Market with Signed Distribut...

Previous 10 Next 10